These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 11078814)
1. Characterization of a fibroblastoid mammary carcinoma cell line (LM2) originated from a mouse adenocarcinoma. Galli S; Colombo L; Vanzuli S; Daroqui MC; del Carmen Vidal M; Jasnis MA; Sacerdote de Lustig E; Eijan AM Int J Oncol; 2000 Dec; 17(6):1259-65. PubMed ID: 11078814 [TBL] [Abstract][Full Text] [Related]
2. Characterization of F3II, a sarcomatoid mammary carcinoma cell line originated from a clonal subpopulation of a mouse adenocarcinoma. Alonso DF; Farías EF; Urtreger A; Ladeda V; Vidal MC; Bal De Kier Joffé E J Surg Oncol; 1996 Aug; 62(4):288-97. PubMed ID: 8691844 [TBL] [Abstract][Full Text] [Related]
3. Varying patterns of expression of insulin-like growth factors I and II and their receptors in murine mammary adenocarcinomas of different metastasizing ability. Guerra FK; Eijan AM; Puricelli L; Alonso DF; Bal de Kier Joffé E; Kornblihgtt AR; Charreau EH; Elizalde PV Int J Cancer; 1996 Mar; 65(6):812-20. PubMed ID: 8631597 [TBL] [Abstract][Full Text] [Related]
4. Effects of in vivo culture of murine mammary adenocarcinoma cells on tumor and metastatic growth. Aguirre Ghiso J; Diament M; D'elia I; Bal de Kier Joffé E; Klein S Tumour Biol; 1997; 18(1):41-52. PubMed ID: 8989924 [TBL] [Abstract][Full Text] [Related]
5. Single-chain, urokinase-type plasminogen activator in a tumor model linked to metastatic potential. Kellen JA; Mirakian A; Wong A In Vivo; 1988; 2(2):155-7. PubMed ID: 2979833 [TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of a new murine mammary tumor cell line, BALB/c-MC. Morimoto J; Imai S; Taniguchi Y; Tsubura Y; Hosick HL In Vitro Cell Dev Biol; 1987 Nov; 23(11):755-8. PubMed ID: 3680103 [TBL] [Abstract][Full Text] [Related]
7. Effects of synthetic urokinase inhibitors on local invasion and metastasis in a murine mammary tumor model. Alonso DF; Farías EF; Ladeda V; Davel L; Puricelli L; Bal de Kier Joffé E Breast Cancer Res Treat; 1996; 40(3):209-23. PubMed ID: 8883963 [TBL] [Abstract][Full Text] [Related]
8. Urokinase-type plasminogen activator activity increases during the growth of two murine mammary adenocarcinomas with different metastasizing abilities. Pereyra-Alfonso S; Solarz GR; Bal de Kier Joffé E Clin Exp Metastasis; 1992 Nov; 10(6):395-401. PubMed ID: 1451349 [TBL] [Abstract][Full Text] [Related]
9. Hypoxia-induced nitric oxide release by luminal cells stimulates proliferation and uPA secretion of myoepithelial cells in a bicellular murine mammary tumor. Krasnapolski MA; Lodillinsky C; Bal De Kier Joffé E; Eiján AM J Cancer Res Clin Oncol; 2015 Oct; 141(10):1727-38. PubMed ID: 25687381 [TBL] [Abstract][Full Text] [Related]
10. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model. Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700 [TBL] [Abstract][Full Text] [Related]
11. Malignant myoepithelial cells are associated with the differentiated papillary structure and metastatic ability of a syngeneic murine mammary adenocarcinoma model. Bumaschny V; Urtreger A; Diament M; Krasnapolski M; Fiszman G; Klein S; Joffé EB Breast Cancer Res; 2004; 6(2):R116-29. PubMed ID: 14979922 [TBL] [Abstract][Full Text] [Related]
12. Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) in the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model. Frandsen TL; Holst-Hansen C; Nielsen BS; Christensen IJ; Nyengaard JR; Carmeliet P; Brünner N Cancer Res; 2001 Jan; 61(2):532-7. PubMed ID: 11212246 [TBL] [Abstract][Full Text] [Related]
13. Combined treatment with verapamil, a calcium channel blocker, and B428, a synthetic uPA inhibitor, impairs the metastatic ability of a murine mammary carcinoma. Todaro LB; Ladeda V; Bal de Kier Joffé E; Farías EF Oncol Rep; 2003; 10(3):725-32. PubMed ID: 12684650 [TBL] [Abstract][Full Text] [Related]
14. Metastatic potential of hyperplastic alveolar nodule derived mouse mammary tumor cells following intravenous inoculation. Anderson LW; Danielson KG; Hosick HL Eur J Cancer Clin Oncol; 1981 Sep; 17(9):1001-8. PubMed ID: 7198982 [No Abstract] [Full Text] [Related]
15. Impairment of fibrinolysis during the growth of two murine mammary adenocarcinomas. Alonso DF; Farías EF; Bal de Kier Joffé E Cancer Lett; 1993 Jul; 70(3):181-7. PubMed ID: 8353814 [TBL] [Abstract][Full Text] [Related]
16. Evidence for paracrine regulation of experimental metastasis in 13762NF rat mammary adenocarcinoma cell clones. Welch DR; Aeed PA; Earhart RH; McClure SA Anticancer Res; 1994; 14(5A):1743-51. PubMed ID: 7847807 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of the metastasis of Lewis lung carcinoma by antibody against urokinase-type plasminogen activator in the experimental and spontaneous metastasis model. Kobayashi H; Gotoh J; Shinohara H; Moniwa N; Terao T Thromb Haemost; 1994 Apr; 71(4):474-80. PubMed ID: 8052966 [TBL] [Abstract][Full Text] [Related]
18. Low adhesiveness coupled with high superinvasiveness in vitro predicts the in vivo metastatic potential of a mouse mammary adenocarcinoma cell line. Glynn SA; Adams A; Gibson B; Cronin D; Harmey JH; Clynes M Anticancer Res; 2006; 26(2A):1001-10. PubMed ID: 16619499 [TBL] [Abstract][Full Text] [Related]
19. [MA891--an established spontaneous mouse mammary adenocarcinoma cell line and its immunologic characteristics]. Zhou Y; Luo L; Liu X; Gao P; Su Y Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Aug; 19(4):273-7. PubMed ID: 10453566 [TBL] [Abstract][Full Text] [Related]
20. Metastasis of murine mammary tumour lines from the mammary gland and ectopic sites. Unemori EN; Ways N; Pitelka DR Br J Cancer; 1984 May; 49(5):603-14. PubMed ID: 6722008 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]